Physician

Nitesh M Patel, D.O.

According to 2025 Medicare claims, Nitesh Patel, D.O. (NPI: 1639360910) practices nephrology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is NORTHEAST KIDNEY CARE LLC (NPI: 1023889565; TIN: 933742471) and primary practice location at 08360-6911.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 726 traditional Medicare patients, billed 2,412 HCPCS/CPT codes, and received $258,705 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,815 prescription claims across 449 beneficiaries totaling $890,979 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 27 claims. Open Payments data shows 98 records totaling $2,063. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $95,063 to $890,979. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	661	1,904	$184,682
2016	716	2,278	$219,609
2017	945	3,028	$416,024
2018	900	3,026	$317,792
2019	972	2,949	$266,951
2020	778	2,527	$249,923
2021	783	2,511	$268,148
2022	824	2,317	$249,502
2023	760	2,266	$294,000
2024	726	2,412	$258,705

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	100	518	$95,063
2016	109	840	$107,091
2017	141	860	$201,783
2018	183	977	$171,984
2019	258	1,614	$312,811
2020	263	1,856	$432,400
2021	276	1,803	$335,126
2022	293	1,908	$411,191
2023	398	2,368	$741,798
2024	449	2,815	$890,979

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	35	$2,701
2020	N/R	23	$1,340
2021	N/R	11	$739
2022	N/R	46	$2,198
2023	N/R	12	$1,224
2024	N/R	27	$1,722

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	134	147	$104
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	76	108	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	180	311	$75
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	354	784	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	171	312	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	164	10,308	$188,078
Jardiance	Empagliflozin	118	6,697	$125,100
Kerendia	Finerenone	68	5,040	$101,492
Auryxia	Ferric Citrate	41	2,130	$90,719
Rayaldee	Calcifediol	71	2,278	$64,032

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	12	$1,439
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	98	$2,063	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nitesh M. Patel, D.O.?

Tedicare shows public-source Medicare data for Nitesh M. Patel, D.O. (NPI 1639360910), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nitesh M. Patel, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nitesh M. Patel, D.O.?

Nitesh M. Patel, D.O. is linked to NORTHEAST KIDNEY CARE LLC (billing NPI 1023889565) in the available physician profile data.

Does Nitesh M. Patel, D.O. have Open Payments data?

Nitesh M. Patel, D.O. has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.